In 2020, BIOTESTLAB Ltd. took another step forward in the development of foreign economic activity. So, last year the company received 11 registration certificates for drugs, including those in new markets.
Olena Saliy, Director of BIOTESTLAB Ltd.: “One of the most promising agricultural markets in the world — Vietnamese, with a professional and complex process of registration of veterinary products, opened the door for us. We have received registration certificates for poultry vaccines Polimun IBD, Polimun IBD+, Polimun ND, and Polimun AE+Pox, as well as the antibiotic Danoxan-25, which is used to treat pigs and cattle. Disinfectants Virosan and Virosan Max have been also presented on the market".
Two more vaccines (Polimun AE, Polimun AE+Pox) have been registered in Egypt. Thus, from now on, 20 vaccines produced by BIOTESTLAB have been presented in that country. Four vaccines (Polimun IBD Light, Polimun La-Sota, Polimun Pox for poultry, and Bovimun LSD for cattle) are presented in Azerbaijan.
In addition to the Vietnam market, last year the company carried out its first export deliveries to Japan, UAE, Kuwait, Bahrain, and some other countries.
Olena Saliy, Director of BIOTESTLAB Ltd.: "Our strategic goal is to increase the export share. The research potential of the company, modern facilities, and a wide range of vaccines, chemical-pharmaceutical drugs, and disinfectants provide opportunities to enter international markets. Nowadays, BIOTESTLAB products are represented in more than 20 countries. Our priority markets are the Middle East, Central and Southeast Asia. At the same time, if previously we used to look for partners abroad, today we regularly receive offers of cooperation from foreign distributors. For example, products are currently being registered in Saudi Arabia, Jordan, Pakistan, Tajikistan, and several African countries”.
Let us remind you that at the end of last year, BIOTESTLAB Ltd. received the conclusion from the Certification Body of Products, Processes, and Services “Ukrainian Biological Certification Center”, on the compliance of veterinary drugs production sites with the requirements of Good Manufacturing Practice (GMP).